Search for: "Holman v. Cook"
Results 1 - 14
of 14
Sorted by Relevance
|
Sort by Date
13 May 2016, 8:00 am
John Stuckey, as Attorney-in-Fact for Robert Holman v. [read post]
13 May 2016, 8:00 am
John Stuckey, as Attorney-in-Fact for Robert Holman v. [read post]
13 May 2016, 8:00 am
John Stuckey, as Attorney-in-Fact for Robert Holman v. [read post]
7 Dec 2010, 9:59 pm
Noonan -- Two academic amici -- Robert Cook-Deegan (at right), Research Professor and Director, Center for Public Genomics at Duke University, and Christopher Holman, Ph.D. [read post]
2 Nov 2015, 8:00 am
Johnnie Stuckey for Robert Holman v. [read post]
6 Feb 2013, 12:42 pm
Holman, Associate Professor of Law at the University of Missouri Kansas City School of Law. [read post]
31 Jan 2013, 7:50 am
In early February, the blog will host an online symposium to discuss how the Court should rule (and why) on the question presented by Association for Molecular Pathology v. [read post]
7 Feb 2013, 6:20 am
Meanwhile, this blog’s symposium on gene patenting continues with contributions from Christopher Holman, Kevin Noonan, Rob Merges, and Robert Cook-Deegan. [read post]
19 Sep 2016, 8:00 am
Moseson v. [read post]
19 Sep 2016, 8:00 am
Moseson v. [read post]
9 May 2013, 9:22 am
One of the central policy issues injected into the current case of AMP v. [read post]
29 Mar 2011, 7:59 am
Boyd is scheduled to die by lethal injection at Holman Prison in Atmore at 6 p.m. [read post]
8 Feb 2008, 7:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Record labels sue Baidu over providing links to file-sharing sites: (Ars Technica), (Techdirt), (Out-Law), (IP Law360), (Copyfight), Merck’s Fosamax patent expires: Watson Pharmaceuticals to distribute authorized generic version, Teva and Barr also launch FDA approved generic versions: (SmartBrief), (Patent Circle), (In … [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in… [read post]
